Isaac Ro
InvestorPartner at Catalio Capital Management, LP · Board director at PrognomIQ
New York, New York, United States
About
Isaac Ro is a Partner at Catalio Capital Management. He was previously Executive Chairman of Haystack Oncology (sold to Quest Diagnostics), CFO of Sema4, which he took public in 2021, and CFO of Thrive Earlier Detection (sold to Exact Sciences). Earlier he led U.S. Medical Technology and Life Science Tools equity research teams at Goldman Sachs and held a similar role at Leerink Partners, and he holds a B.A. in History from Middlebury College.
Contact· self-published, not guessed
Invests in
BiotechDigital HealthMedical Devices
Board director at PrognomIQ
Intro paths
→
In turn, Isaac can intro founders to PrognomIQ's investors below.
PrognomIQ's investors · 4
Co-founders at PrognomIQ
PM
Philip Ma, Ph.D.Executive Officer, Director
Experience
- Catalio Capital ManagementPartnercurrent2023 — presentNew York
- SeerBoard Membercurrent2025 — presentRedwood City, California, United States
- PinkDx, Inc.Board Membercurrent2023 — presentDaly City, California, United States
- PrognomiQ IncBoard Membercurrent2024 — presentSan Mateo, California, United States
- MedraBoard Observercurrent2026 — present
- Axena HealthBoard Observercurrent2025 — presentNewton, Massachusetts, United States
- Volta Labs, Inc.Board Observercurrent2025 — presentCambridge, Massachusetts, United States
- Visby MedicalBoard Observercurrent2025 — presentSan Jose, California, United States
- AnagenexBoard Member2023 — 2025Lexington, Massachusetts, United States
- Pillar Biosciences IncorporatedBoard Observer2023 — 2024Waltham, Massachusetts, United States
- Haystack OncologyExecutive Chairman2022 — 2023Baltimore, Maryland
- GeneDxChief Financial Officer2021 — 2022Stamford, Connecticut
- Exact SciencesChief Financial Officer2019 — 2021Cambridge, Massachusetts
- Goldman SachsVice President2010 — 2019New York
- Leerink PartnersDirector2004 — 2010New York
- RBCResearch Associate2003 — 2004Boston, Massachusetts
- Aberdeen Strategy & ResearchResearch Associate2000 — 2003Boston, Massachusetts
- Harvard Medical SchoolLaboratory Technician1999Brookline, Massachusetts, United States
Skills & more
Bloomberg6Strategic ConsultingEquity Research23Valuation41Financial Analysis21Investments40Jokes3Gift of Gab3Financial Modeling39Private Equity6Corporate Development5Investment Banking7
+7 more
Emerging MarketsDue DiligenceHedge FundsMergersCapital MarketsEquitiesMergers & AcquisitionsFrom Isaac's professional profile.
Investments
Board seats
Pink Dx.PrognomIQVisby Medical
Per the firm's website.
Colleagues at Catalio Capital Management, LP
Adam Riess
Venture Partner at Catalio Capital Management, LP
Alan Ashworth
Venture Partner at Catalio Capital Management, LP
Christine E. 'Kricket' Seidman
Venture Partner at Catalio Capital Management, LP
Dan Littman
Venture Partner at Catalio Capital Management, LP
David Sinclair
Venture Partner at Catalio Capital Management, LP
Diamantis Xylas
Analyst at Catalio Capital Management, LP
Frances H. Arnold
Venture Partner at Catalio Capital Management, LP
Freda Lewis-Hall
Venture Partner at Catalio Capital Management, LP
Frequently asked questions
- Who is Isaac Ro?
- Isaac Ro is a Partner at Catalio Capital Management. He was previously Executive Chairman of Haystack Oncology (sold to Quest Diagnostics), CFO of Sema4, which he took public in 2021, and CFO of Thrive Earlier Detection (sold to Exact Sciences). Earlier he led U.S. Medical Technology and Life Science Tools equity research teams at Goldman Sachs and held a similar role at Leerink Partners, and he holds a B.A. in History from Middlebury College.
- Where does Isaac Ro work?
- Isaac Ro is Partner at Catalio Capital Management, LP and Board director at PrognomIQ.
- What does Isaac Ro invest in?
- Isaac Ro invests in Biotech, Digital Health, Medical Devices.
- What boards does Isaac Ro sit on?
- Isaac Ro holds tracked board seats at Pink Dx., PrognomIQ, Visby Medical.
- Where did Isaac Ro go to school?
- Isaac Ro studied at Middlebury College (BA with Honors in History, Pre-Med); Harvard Extension School (Vertebrate Anatomy); St. Paul's School (Cum Laude).
Same school
Also attended Middlebury College129
Parker HarrisCo-founder of SalesforceAlex FinkelsteinInvestor at Spark CapitalJeff DoranInvestor at Spark CapitalTrevor KienzleInvestor at Correlation VenturesUrvashi BarooahPartner at Redpoint VenturesEnzo WienerPrincipal at Redpoint Ventures
+ 123 more
Also attended Harvard Extension School29
Luca FerraresiProject Specialist at P101 VenturesRob PurintonChief Artificial Intelligence Officer at Flare Capital PartnersMascha BonkSenior Associate at Hitachi VenturesGabi ZijderveldCo-Founder and Operating Partner at Blue Tulip VenturesJosh Hoffman-SennGeneral Partner at The MBA FundJohn ShufeldtGeneral Partner at Xcellerant Ventures
+ 23 more
Also attended St. Paul's School21
Max AbramPartner at Scale Venture PartnersTom LoverroInvestor at IVP (Institutional Venture Partners)Trevor EcklerAnalyst at Volition CapitalElisabeth SpencerAssociate — Endurance at Energize VenturesRoberto AvilaPartner at Sageview CapitalHendrick LeeFounding Partner at Palm Drive Capital
+ 15 more
Shared employers
Also worked at PinkDx, Inc.3
Also worked at GeneDx1
Also worked at Goldman Sachs1,505
Josh KushnerFounder & CEO of Thrive CapitalSarah GuoFounder & General Partner of ConvictionFred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeMatt HuangCo-founder and Managing Partner at ParadigmDavid VélezFounder & CEO of NubankTarek MansourCo-founder & CEO of Kalshi
+ 1,499 more
Also worked at Leerink Partners9
Sebastian GranizoVenture Capital Associate at Plum Alley InvestmentsSocrates ZachariasPrincipal at BIOSPRING PARTNERSMark AdamsPartner at Two Bear CapitalStephen RenfroPartner and Chief Operations Officer at Optum VenturesJohn SullivanVenture Partner at Two Bear CapitalChad PallopsonVenture Partner at Archangel Network of Funds
+ 3 more